These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Your patients face the treatment of osteoporosis: How to improve the efficacy of management in clinical practice?]. Thomas T; Reach G; Lespessailles E Rev Prat; 2006 Jan; Spec No():3-11. PubMed ID: 16502833 [No Abstract] [Full Text] [Related]
24. Potential impact of osteoporosis treatment on hip fracture trends. Melton LJ; Kanis JA; Johnell O J Bone Miner Res; 2005 Jun; 20(6):895-7. PubMed ID: 15883627 [No Abstract] [Full Text] [Related]
26. [Treating with what? Therapy for how long?]. MMW Fortschr Med; 2005 Dec; 147(51-52):62-3. PubMed ID: 16402713 [No Abstract] [Full Text] [Related]
27. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. Iwamoto J; Takeda T; Sato Y Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313 [TBL] [Abstract][Full Text] [Related]
28. Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective. Wasserfallen JB; Krieg MA; Greiner RA; Lamy O J Med Econ; 2008; 11(3):499-523. PubMed ID: 19450101 [TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone. Madore GR; Sherman PJ; Lane JM J Am Acad Orthop Surg; 2004; 12(2):67-71. PubMed ID: 15089079 [No Abstract] [Full Text] [Related]
35. Health-economic comparison of three recommended drugs for the treatment of osteoporosis. Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171 [TBL] [Abstract][Full Text] [Related]
36. Treatment of postmenopausal osteoporosis with etidronate. Heyneman CA Ann Pharmacother; 1993 Oct; 27(10):1200-1. PubMed ID: 8251688 [No Abstract] [Full Text] [Related]
37. Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis. Ste-Marie LG; Sod E; Johnson T; Chines A Calcif Tissue Int; 2004 Dec; 75(6):469-76. PubMed ID: 15478000 [TBL] [Abstract][Full Text] [Related]
38. [Osteoporosis treatment: the point of view of the gynecologist]. Lopes P Contracept Fertil Sex; 1998 Jun; 26(6):408-11. PubMed ID: 9691516 [No Abstract] [Full Text] [Related]
39. [Risedronate (Actonel)--from randomized clinical trials to real life]. Anić B Reumatizam; 2007; 54(2):85-6. PubMed ID: 18351152 [No Abstract] [Full Text] [Related]
40. Pharmacoeconomic analysis of osteoporosis treatment with risedronate. Brecht JG; Kruse HP; Felsenberg D; Möhrke W; Oestreich A; Huppertz E Int J Clin Pharmacol Res; 2003; 23(4):93-105. PubMed ID: 15224498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]